Virtu Financial’s Catalyst Pharmaceutical CPRX Stock Holding History

Virtu Financial’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$396K	Buy	+12,600	New	+$372K	0.01%	615
2024 Q2	–	Sell	-11,978	Closed	-$191K	–	1395
2024 Q1	$191K	Buy	+11,978	New	+$180K	0.01%	802
2022 Q4	–	Sell	-88,892	Closed	-$1.14M	–	1700
2022 Q3	$1.14M	Buy	+88,892	New	+$1.05M	0.1%	171
2021 Q3	–	Sell	-13,295	Closed	-$76K	–	1572
2021 Q2	$76K	Buy	+13,295	New	+$68.6K	0.01%	1262
2020 Q4	–	Sell	-62,022	Closed	-$184K	–	1488
2020 Q3	$184K	Buy	+62,022	New	+$243K	0.03%	604
2019 Q4	$40K	Buy	+10,725	New	+$50.2K	﹤0.01%	1235
2019 Q2	–	Sell	-112,568	Closed	-$574K	–	1505
2019 Q1	$574K	Buy	112,568 +8,062	+8%	+$23.7K	0.03%	500
2018 Q4	$201K	Buy	+104,506	New	+$299K	0.01%	960
2018 Q1	–	Sell	-16,764	Closed	-$66K	–	2039
2017 Q4	$66K	Sell	16,764 -13,608	-45%	-$45K	﹤0.01%	2020
2017 Q3	$77K	Buy	+30,372	New	+$83.3K	﹤0.01%	2134

Other funds holding CPRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Virtu Financial's CPRX Position: Q2 2026 in Review

Virtu Financial opened a new position in Catalyst Pharmaceutical (CPRX) in Q2 2026: 12,600 shares worth $396K. The stake represents 0.01% of the portfolio and ranks #615 among its holdings. This is a return to the name: Virtu Financial previously reported a position in CPRX as recently as Q1 2024.

Virtu Financial first reported a position in CPRX in Q3 2017 and has held it in 10 quarters since. The position peaked at $1.14M in Q3 2022. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

Virtu Financial held 12,600 shares of Catalyst Pharmaceutical worth $396K as of Q2 2026.
Catalyst Pharmaceutical was a new Virtu Financial position in Q2 2026.
Catalyst Pharmaceutical made up 0.01% of Virtu Financial's portfolio in Q2 2026, its #615 holding.
Virtu Financial first reported a position in Catalyst Pharmaceutical in Q3 2017 and has held it in 10 quarters since.
Virtu Financial's Catalyst Pharmaceutical position peaked at $1.14M in Q3 2022.
396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.